Css LLC Aptinyx Inc. Call Options Transaction History

Css LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $2.58 $19,000 - $129,000	-50,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.27 - $3.62 $113,500 - $181,000	50,000 New	50,000 $114,000
Q2 2021 Aug 16, 2021	SELL	$2.39 - $3.5 $24,617 - $36,050	-10,300 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.86 - $4.33 $10,010 - $15,155	3,500 Added 51.47%	10,300 $30,000
Q4 2020 Feb 16, 2021	BUY	$2.93 - $4.3 $19,924 - $29,240	6,800 New	6,800 $24,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.